We previously identified the cyclic-AMP/phosphodiesterase 4 (PDE4) axis as a critical modulator of B-cell receptor (BCR) signals and PI3K activity in DLBCL. The gene discussed is PDE4A; the disease is diffuse large B-cell lymphoma.